Thomaspartners’s Bristol-Myers Squibb BMY Stock Holding History

Thomaspartners’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-9,179	Closed	-$543K	–	87
2015 Q3	$543K	Sell	9,179 -482	-5%	-$30.6K	0.01%	82
2015 Q2	$643K	Buy	9,661 +87	+0.9%	+$5.73K	0.01%	84
2015 Q1	$617K	Sell	9,574 -522	-5%	-$32.7K	0.01%	86
2014 Q4	$596K	Sell	10,096 -224	-2%	-$12.6K	0.01%	91
2014 Q3	$528K	Buy	10,320 +730	+8%	+$36.5K	0.01%	92
2014 Q2	$466K	Buy	9,590 +213	+2%	+$10.5K	0.01%	91
2014 Q1	$488K	Buy	9,377 +40	+0.4%	+$2.13K	0.01%	92
2013 Q4	$496K	Sell	9,337 -426	-4%	-$21.7K	0.01%	93
2013 Q3	$452K	Buy	9,763 +198	+2%	+$8.69K	0.02%	98
2013 Q2	$441K	Buy	+9,565	New	+$415K	0.02%	103

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LTI

Laffer Tengler Investments Nashville, Tennessee $677M AUM 27.58% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Thomaspartners's BMY Position: Q4 2015 in Review

Thomaspartners sold out of Bristol-Myers Squibb (BMY) in Q4 2015, closing a stake of 9,179 shares — an estimated $543K sold.

Thomaspartners first reported a position in BMY in Q2 2013 and held it in 10 quarters. The position peaked at $643K in Q2 2015. 1,534 funds tracked by Wall St. Rank hold BMY as of Q4 2015.

Thomaspartners reported no remaining Bristol-Myers Squibb position as of Q4 2015 after selling out during the quarter.
Thomaspartners sold 9,179 Bristol-Myers Squibb shares in Q4 2015, an estimated $543K.
Thomaspartners first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 10 quarters.
Thomaspartners's Bristol-Myers Squibb position peaked at $643K in Q2 2015.
1,534 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2015.

Based on Thomaspartners's 13F filing for Q4 2015, filed 16 Feb 2016.